Royalty Pharma

RPRX

Market cap $15.6B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$46

27% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Morgan Stanley Terence Flynn 100% 1-yr win rate				10 Oct ‘25 5 days ago
Goldman Sachs Asad Haider 100% 1-yr win rate				30 Sep ‘25 15 days ago
Citigroup Geoff Meacham 100% 1-yr win rate				22 Jul ‘25 2 months ago